Range
5.02 - 5.22
Vol / Avg.
55.1K/133.9K
Div / Yield
-
52 Wk
3.5 - 36.1
Mkt Cap
159.5M
Payout Ratio
-
Open
5.22
P/E
-
EPS
-0.48
Shares
31.5M
Outstanding
31.5M
Total Float
-
Benzinga - May 12, 2021, 6:18AM
Benzinga - May 11, 2021, 4:13PM
Benzinga - Mar 25, 2021, 5:01PM
Benzinga - Mar 2, 2021, 8:21AM
Benzinga - Mar 2, 2021, 6:10AM
Benzinga - Mar 1, 2021, 10:56AM
Benzinga - Mar 1, 2021, 8:43AM
Benzinga - Mar 1, 2021, 7:08AM
Benzinga - Mar 1, 2021, 7:07AM
Benzinga - Nov 10, 2020, 4:04PM
Benzinga - Sep 21, 2020, 10:14AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Satsuma Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.400-0.480 -0.0800
REV0
Q4 2020Est.ActualSurprise
EPS-0.720
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
STSASatsuma Pharmaceuticals-1.56%159.5M

Satsuma Pharmaceuticals Frequently Asked Questions

Q

How do I buy Satsuma Pharmaceuticals (STSA) stock?

A

You can purchase shares of Satsuma Pharmaceuticals (NASDAQ: STSA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Satsuma Pharmaceuticals's (STSA) competitors?

A

Other companies in Satsuma Pharmaceuticals’s space includes: Graybug Vision (NASDAQ:GRAY), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX), Hepion Pharmaceuticals (NASDAQ:HEPA) and Aquestive Therapeutics (NASDAQ:AQST).

Q

What is the target price for Satsuma Pharmaceuticals (STSA) stock?

A

The latest price target for Satsuma Pharmaceuticals (NASDAQ: STSA) was reported by SVB Leerink on May 12, 2021. The analyst firm set a price target for 5.00 expecting STSA to fall to within 12 months (a possible -1.19% downside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Satsuma Pharmaceuticals (STSA)?

A

The stock price for Satsuma Pharmaceuticals (NASDAQ: STSA) is $5.06 last updated Today at 7:05:00 PM.

Q

Does Satsuma Pharmaceuticals (STSA) pay a dividend?

A

There are no upcoming dividends for Satsuma Pharmaceuticals. The last dividend paid out to investors was $0.02 on March 28, 2014.

Q

When is Satsuma Pharmaceuticals (NASDAQ:STSA) reporting earnings?

A
Satsuma Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 11, 2021.
Q

Is Satsuma Pharmaceuticals (STSA) going to split?

A

There is no upcoming split for Satsuma Pharmaceuticals.

Q

What sector and industry does Satsuma Pharmaceuticals (STSA) operate in?

A

Satsuma Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.